Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin®) injections in blepharospasm

@inproceedings{Truong2013SustainedEA,
  title={Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin®) injections in blepharospasm},
  author={Daniel D. Truong and Stephen M. Gollomp and Joseph Jankovic and Peter A Lewitt and Michael Marx and Angelika Hanschmann and Hubert Henery Fernandez},
  booktitle={Journal of Neural Transmission},
  year={2013}
}
IncobotulinumtoxinA (Xeomin®, NT 201) is a purified botulinum toxin type A free from accessory (complexing) proteins. Previous studies evaluated single sets of incobotulinumtoxinA injections for the treatment of blepharospasm. Individualized injection intervals and other potential determinants of efficacy and safety need to be evaluated in a prospective, longitudinal study. Subjects with blepharospasm who completed a ≤20 weeks double-blind, placebo-controlled main period entered a ≤69 weeks… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 23 references

Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm

  • P Roggenkämper, WH Jost, K Bihari, G Comes, S Grafe
  • J Neural Transm
  • 2006
Highly Influential
11 Excerpts

Similar Papers

Loading similar papers…